Skip to main content

BioVenture — Portfolio, Page 4

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

274
Companies
$1.0B
Total invested
$20.1M
Avg. check
23
Industries
Biotechnology 18Medical 13Biopharma 10Health Care 10Therapeutics 8Pharmaceutical 5+17 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 7396 of 274
BOOST Pharma
November 2025

BOOST Pharma develops a stem cell therapy for the treatment of osteogenesis imperfecta.

Biopharma · Copenhagen$3.6M Venture - Series Unknown
HotSpot Therapeutics
November 2021

HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.

Biopharma · Boston$100.0M Series C
NanoMosaic
November 2025

NanoMosaic provides solutions for early illness detection, prognostic monitoring, and biomarker identification.

Biopharma · Waltham$3.0M Venture - Series Unknown
Valora Therapeutics
November 2024

Valora Therapeutics is a biotechnology company that provides engineering of chimeric antibodies .

Biopharma · La Jolla$30.0M Seed
Tavotek Biotherapeutics
November 2021

Tavotek Biotherapeutics focused on discovering, acquiring, developing, and commercializing therapeutic medicines.

Biopharma · Gwynedd$35.0M Series B
Treadwell Therapeutics
November 2021

Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.

Biotechnology · New York$91.0M Series B
eGlint
November 2021

Developer of a miniature biosensing device intended to use a small blood volume to derive data on multiple biomarkers present in the sample.

Analytics · San Diego$2.4M Seed
Breye Therapeutics
November 2022

Breye Therapeutics, a biopharmaceutical firm that provide cutting-edge oral treatments for the management of retinal vascular diseases.

Biopharma · Hørsholm$4.1M Seed
Lipidio Pharmaceuticals
November 2022

Lipidio Pharmaceuticals focuses on advancing a molecule to treat diseases associated with excess body fat.

Biopharma · San Diego$20.0M Series A
Gate Neurosciences
October 2022

Gate Neurosciences is a healthcare company that offers neuroscience-related medical services.

Biotechnology · Carmel$25.0M Venture - Series Unknown
IpiNovyx Bio
October 2021

IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.

Biopharma · West Nyack$10.0M Seed
OncoC4
October 2025

OncoC4 is a biopharmaceutical company that engages in the discovery and development of novel biologicals for cancer treatment.

Biopharma · Rockville$50.0M Series B
Modifi Bio
October 2023

Modifi Biosciences is a direct DNA modification developing novel cancer therapeutics.

Biotechnology · New Haven$4.3M Seed
Pelage Pharmaceuticals
October 2025

Pelage Pharma is a regenerative medicine biotechnology company developing treatments for hair loss.

Health Care · Los Angeles$120.0M Series B
DeepSight Technology
October 2021

DeepSight Technology's vision is to reinvent diagnostic imaging.

Medical Device · San Francisco$25.0M Series A
Tianhu Technology
March 2026

Tianhu Technology is a computational chemistry and AI-driven innovative drug molecule design provider.

Alternative Protein · Minhang$29.0M Series A
AccuPulse
March 2026

AccuPulse is developing novel pulsed electric field ablation (PFA) generator and catheters.

Health Care · Suzhou$14.5M Series B
Yili Pharmaceutical
March 2026

Yili Pharmaceutical is a pharmaceutical R&D company.

Biotechnology · Hangzhou$14.5M Seed
Lingchu Intelligence
March 2026

Lingchu is an embodied intelligence startup company that specializes in robot skill set training using reinforcement learning algorithms

Robotics · Haidian$290.4M Seed
Theolytics
March 2026

Theolytics is a clinical stage biotechnology company developing next-generation viral therapies.

Biotechnology · Oxford$9.3M Grant
Chromai
February 2026

Chromai offers high-performance intelligent liquid chromatography and medical diagnostic solutions.

Health Care · ShunyiSeries Unknown
Praeventix
February 2026

Praeventix is a biotechnology company developing therapeutics to treat bowel diseases.

Biotechnology · Exton$3.0M Series Unknown
LB Pharmaceuticals
February 2026

LB Pharmaceuticals specializes in developing LB-102 (n-Methyl amisulpride) as a treatment for schizophrenia.

Biopharma · New York$100.0M Post Ipo Equity
NeuShen Therapeutics
January 2026

NeuShen Therapeutics is a biotechnology company trailblazing the future treatment of neurological and psychiatric disorders.

Biotechnology · ShanghaiSeries A

Where BioVenture invests

Biotechnology18
Medical13
Biopharma10
Health Care10
Therapeutics8
Pharmaceutical5

About BioVenture's portfolio

How many companies has BioVenture invested in?

BioVenture has invested in 274 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does BioVenture invest in?

BioVenture's top investment sectors include Biotechnology, Medical, Biopharma, Health Care, Therapeutics. The firm invests across 23 different industry categories.

What is BioVenture's largest investment?

Among tracked funding rounds, Lingchu Intelligence received $290.4M in a Seed round. BioVenture's total known invested capital is $1.0B.

What is the average investment size for BioVenture?

BioVenture's average investment size is $20.1M across its portfolio of 274 companies.

What are BioVenture's most recent investments?

Recent BioVenture portfolio additions include BOOST Pharma, HotSpot Therapeutics, NanoMosaic, Valora Therapeutics, Tavotek Biotherapeutics. These companies were founded in 2020 or later.

Reach the founders behind these 274 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →